Merck & Co (NY: MRK )
102.94 -0.52 (-0.50%) Official Closing Price Updated: 7:00 PM EST, Feb 3, 2023 Add to My Watchlist
Press Releases about Merck & Co
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
February 02, 2023
Merck Completes Tender Offer to Acquire Imago BioSciences, Inc.
January 11, 2023
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
December 12, 2022
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
December 05, 2022
From Brodsky & Smith LLC
Via Globe NewsWire
Merck to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 21, 2022
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
Topics Intellectual Property
Exposures Intellectual Property